BioBAT Brings Bioscience Research To Brooklyn, New York
"With the development of BioBAT, together with the East River Science Park set to open this fall, we are building 10 times the amount of commercial lab space that's currently available," said New York City Mayor Michael R. Bloomberg.
The City invested $12 million in the project, and the state offered $48 million of funding. Some organizations, such as the International AIDS Vaccine Initiative, are already located there, and will be joined by several others.
"BioBAT's laboratory, office, and manufacturing space on the Brooklyn waterfront is designed for larger companies and offers affordable rents, convenient transportation, and access to all the leading academic research centers in the city," said SUNY Downstate President John C. LaRosa.
The Brooklyn Army Terminal is a 97-acre facility owned by the city and managed by the New York City Economic Development Corporation. BioBAT is a nonprofit corporation that was created to encourage the development of commercial bioscience research, development, and manufacturing in Brooklyn. The architecture firm HOK will design the facility.
2022 Top States for Doing Business Provide an Environment for Business Growth
Location Factors in the EV Industry — “Mission Critical” or “Nice to Have”?
2022 Auto/Aero Site Guide
Three Big Challenges Facing the Food & Beverage Industry
How Are Economic Developers Partnering to Solve Workforce Challenges?
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Fixing the Supply Chain with AI and Robotics
18th Annual Consultants Survey: Access to Major Markets and Skilled Labor Are Clients’ Primary Concerns